TY - JOUR
T1 - A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
AU - MAFLD ICD-11 coding collaborators
AU - Zhang, Huai
AU - Targher, Giovanni
AU - Byrne, Christopher D.
AU - Kim, Seung Up
AU - Wong, Vincent Wai Sun
AU - Valenti, Luca
AU - Glickman, Myer
AU - Ponce, Jaime
AU - Mantzoros, Christos S.
AU - Crespo, Javier
AU - Gronbaek, Henning
AU - Yang, Wah
AU - Eslam, Mohammed
AU - Wong, Robert J.
AU - Machado, Mariana Verdelho
AU - Yu, Ming Lung
AU - Ghanem, Omar M.
AU - Okanoue, Takeshi
AU - Liu, Jun Feng
AU - Lee, Yong Ho
AU - Xu, Xiao Yuan
AU - Pan, Qiuwei
AU - Sui, Meili
AU - Lonardo, Amedeo
AU - Yilmaz, Yusuf
AU - Zhu, Li Yong
AU - Moreno, Christophe
AU - Miele, Luca
AU - Lupsor-platon, Monica
AU - Zhao, Lei
AU - Lamasters, Teresa Leann
AU - Gish, Robert G.
AU - Zhang, Huijie
AU - Nedelcu, Marius
AU - Chan, Wah Kheong
AU - Xia, Ming Feng
AU - Bril, Fernando
AU - Shi, Jun Ping
AU - Datz, Christian
AU - Romeo, Stefano
AU - Sun, Jian
AU - Liu, Dan
AU - Sookoian, Silvia
AU - Mao, Yi Min
AU - Méndez-sánchez, Nahum
AU - Wang, Xiao Yan
AU - Pyrsopoulos, Nikolaos T.
AU - Fan, Jian Gao
AU - Fouad, Yasser
AU - Sun, Dan Qin
N1 - Publisher Copyright:
© Asian Pacific Association for the Study of the Liver 2024.
PY - 2024/8
Y1 - 2024/8
N2 - Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, it is important to establish consensus for the coding of MAFLD in ICD-11. This will inform subsequent revisions of ICD-11. Methods: Using the Qualtrics XM and WJX platforms, questionnaires were sent online to MAFLD-ICD-11 coding collaborators, authors of papers, and relevant association members. Results: A total of 890 international experts in various fields from 61 countries responded to the survey. We also achieved full coverage of provincial-level administrative regions in China. 77.1% of respondents agreed that MAFLD should be represented in ICD-11 by updating NAFLD, with no significant regional differences (77.3% in Asia and 76.6% in non-Asia, p = 0.819). Over 80% of respondents agreed or somewhat agreed with the need to assign specific codes for progressive stages of MAFLD (i.e. steatohepatitis) (92.2%), MAFLD combined with comorbidities (84.1%), or MAFLD subtypes (i.e., lean, overweight/obese, and diabetic) (86.1%). Conclusions: This global survey by a collaborative panel of clinical, coding, health management and policy experts, indicates agreement that MAFLD should be coded in ICD-11. The data serves as a foundation for corresponding adjustments in the ICD-11 revision.
AB - Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, it is important to establish consensus for the coding of MAFLD in ICD-11. This will inform subsequent revisions of ICD-11. Methods: Using the Qualtrics XM and WJX platforms, questionnaires were sent online to MAFLD-ICD-11 coding collaborators, authors of papers, and relevant association members. Results: A total of 890 international experts in various fields from 61 countries responded to the survey. We also achieved full coverage of provincial-level administrative regions in China. 77.1% of respondents agreed that MAFLD should be represented in ICD-11 by updating NAFLD, with no significant regional differences (77.3% in Asia and 76.6% in non-Asia, p = 0.819). Over 80% of respondents agreed or somewhat agreed with the need to assign specific codes for progressive stages of MAFLD (i.e. steatohepatitis) (92.2%), MAFLD combined with comorbidities (84.1%), or MAFLD subtypes (i.e., lean, overweight/obese, and diabetic) (86.1%). Conclusions: This global survey by a collaborative panel of clinical, coding, health management and policy experts, indicates agreement that MAFLD should be coded in ICD-11. The data serves as a foundation for corresponding adjustments in the ICD-11 revision.
KW - Global survey
KW - ICD-11
KW - MAFLD
UR - https://www.scopus.com/pages/publications/85196002868
U2 - 10.1007/s12072-024-10702-5
DO - 10.1007/s12072-024-10702-5
M3 - Article
C2 - 38878111
AN - SCOPUS:85196002868
SN - 1936-0533
VL - 18
SP - 1178
EP - 1201
JO - Hepatology International
JF - Hepatology International
IS - 4
ER -